CTIC logo

CTI BioPharma (CTIC) Current Liabilities

Annual Current Liabilities

$81.13 M
+$14.48 M+21.73%

December 31, 2022

Summary

Performance

1-Year Change

+21.73%

3-Year Change

+338.85%

5-Year Change

+321.3%

15-Year Change

+321.3%

CTIC Current Liabilities Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$81.13 M
CTIC annual total current liabilities is currently at an all-time high

3-Year Low

$66.65 M
CTIC annual total current liabilities is currently +21.73% above its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2022
CTIC previous annual earnings announcement was published on Dec 31, 2022

Next Annual Earnings Report Date

N/A
CTIC next annual earnings announcement has not yet been scheduled

OtherCTICbalance sheetmetrics:

Annual Total Liabilities

$143.50 M
CTIC annual total liabilities is $143.50 million

Annual Total Long Term Liabilities

$62.37 M
CTIC annual total long term liabilities is $62.37 million

Annual Total Assets

$125.92 M
CTIC annual total assets is $125.92 million

Annual Current Assets

$99.40 M
CTIC annual total current assets is $99.40 million

Quarterly Current Liabilities

$68.23 M
-$12.91 M-15.91%

March 31, 2023

Summary

Performance

3-Month Change

-15.91%

1-Year Change

-31.04%

3-Year Change

+373.63%

5-Year Change

+237.08%

CTIC Quarterly Current Liabilities Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$98.93 M
CTIC quarterly total current liabilities is currently -31.04% below its historical high of $98.93 million

3-Year Low

$29.77 M
CTIC quarterly total current liabilities is currently +129.18% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Mar 31, 2023
CTIC previous earnings announcement was published on Mar 31, 2023

Next Quarterly Earnings Report Date

N/A
CTIC next earnings announcement has not yet been scheduled

OtherCTICbalance sheetmetrics:

Quarterly Total Liabilities

$137.62 M
CTIC quarterly total liabilities is $137.62 million

Quarterly Long Term Liabilities

$69.39 M
CTIC quarterly total long term liabilities is $69.39 million

Quarterly Total Assets

$112.27 M
CTIC quarterly total assets is $112.27 million

Quarterly Current Assets

$86.45 M
CTIC quarterly total current assets is $86.45 million

Current Liabilities Formula

Current Liabilities = Accounts Payable + Short-Term Debt + Accrued Expenses + Other Current Liabilities

Annual Current Liabilities

$81.13 M
CTIC annual total current liabilities is $81.13 million

Annual Accounts Payable

$2.01 M
CTIC annual accounts payable is $2.01 million

Annual Short Term Debt

$48.72 M
CTIC annual short term debt is $48.72 million

CTIC Current Liabilities Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+21.7%-31.0%
3 y3 years+338.9%+373.6%
5 y5 years+321.3%+237.1%

CTIC Current Liabilities Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-yearat high-17.9%-31.0%-56.4%
5 y5-yearat high-79.0%-31.0%-79.9%
alltimeall timeat high-94.0%-31.0%-93.0%

CTI BioPharma Current Liabilities History

DateAnnualQuarterly
Mar 2023
-
$68.23 M(-15.9%)
Dec 2022
$81.13 M(+21.7%)
$81.13 M(+172.5%)
Sep 2022
-
$29.77 M(-0.1%)
Jun 2022
-
$29.79 M(-69.9%)
Mar 2022
-
$98.93 M(+48.4%)
Dec 2021
$66.65 M(+291.2%)
$66.65 M(+6.9%)
Sep 2021
-
$62.34 M(+294.8%)
Jun 2021
-
$15.79 M(+1.5%)
Mar 2021
-
$15.56 M(-8.7%)
Dec 2020
$17.04 M(-7.8%)
$17.04 M(+17.3%)
Sep 2020
-
$14.52 M(+5.6%)
Jun 2020
-
$13.74 M(-4.6%)
Mar 2020
-
$14.40 M(-22.1%)
Dec 2019
$18.49 M(-19.8%)
$18.49 M(-33.8%)
Sep 2019
-
$27.92 M(+55.3%)
Jun 2019
-
$17.98 M(+10.9%)
Mar 2019
-
$16.22 M(-29.7%)
Dec 2018
$23.05 M(+19.7%)
$23.05 M(+0.3%)
Sep 2018
-
$23.00 M(+3.4%)
Jun 2018
-
$22.24 M(+9.9%)
Mar 2018
-
$20.24 M(+5.1%)
Dec 2017
$19.26 M(-52.6%)
$19.26 M(-26.5%)
Sep 2017
-
$26.20 M(-28.1%)
Jun 2017
-
$36.46 M(-12.9%)
Mar 2017
-
$41.87 M(+3.0%)
Dec 2016
$40.65 M(-43.9%)
$40.65 M(-12.2%)
Sep 2016
-
$46.30 M(+13.6%)
Jun 2016
-
$40.75 M(-12.1%)
Mar 2016
-
$46.35 M(-36.0%)
Dec 2015
$72.41 M(+99.3%)
$72.41 M(+98.4%)
Sep 2015
-
$36.49 M(+10.2%)
Jun 2015
-
$33.10 M(-6.5%)
Mar 2015
-
$35.38 M(-2.6%)
Dec 2014
$36.34 M(+81.1%)
$36.34 M(+26.1%)
Sep 2014
-
$28.81 M(+21.1%)
Jun 2014
-
$23.79 M(+31.4%)
Mar 2014
-
$18.11 M(-9.8%)
Dec 2013
$20.07 M(-11.5%)
$20.07 M(-2.2%)
Sep 2013
-
$20.53 M(-9.1%)
Jun 2013
-
$22.58 M(+4.0%)
Mar 2013
-
$21.70 M(-4.2%)
Dec 2012
$22.67 M(+27.5%)
$22.67 M(-15.6%)
Sep 2012
-
$26.84 M(-19.6%)
Jun 2012
-
$33.38 M(+122.8%)
Mar 2012
-
$14.98 M(-15.8%)
Dec 2011
$17.78 M(-56.7%)
$17.78 M(-42.3%)
Sep 2011
-
$30.81 M(-16.2%)
Jun 2011
-
$36.78 M(-5.9%)
Mar 2011
-
$39.10 M(-4.8%)
Dec 2010
$41.07 M(-35.7%)
$41.07 M(+58.7%)
Sep 2010
-
$25.87 M(-60.0%)
Jun 2010
-
$64.65 M(+5.1%)
Mar 2010
-
$61.48 M(-3.7%)
DateAnnualQuarterly
Dec 2009
$63.86 M(+51.0%)
$63.86 M(-12.4%)
Sep 2009
-
$72.88 M(+143.7%)
Jun 2009
-
$29.91 M(-19.0%)
Mar 2009
-
$36.94 M(-12.7%)
Dec 2008
$42.30 M(-21.0%)
$42.30 M(+6.5%)
Sep 2008
-
$39.72 M(-20.9%)
Jun 2008
-
$50.20 M(+4.7%)
Mar 2008
-
$47.95 M(-10.5%)
Dec 2007
$53.55 M(+55.8%)
$53.55 M(-34.9%)
Sep 2007
-
$82.28 M(+8.4%)
Jun 2007
-
$75.88 M(+124.5%)
Mar 2007
-
$33.80 M(-1.7%)
Dec 2006
$34.37 M(+11.6%)
$34.37 M(+7.5%)
Sep 2006
-
$31.98 M(+52.3%)
Jun 2006
-
$21.00 M(-29.8%)
Mar 2006
-
$29.91 M(-2.8%)
Dec 2005
$30.79 M(-9.8%)
$30.79 M(-48.8%)
Sep 2005
-
$60.15 M(+16.1%)
Jun 2005
-
$51.81 M(+73.7%)
Mar 2005
-
$29.83 M(-12.6%)
Dec 2004
$34.12 M(+1.8%)
$34.12 M(+15.6%)
Sep 2004
-
$29.50 M(-4.4%)
Jun 2004
-
$30.86 M(-17.2%)
Mar 2004
-
$37.25 M(+11.1%)
Dec 2003
$33.52 M(+56.0%)
$33.52 M(+28.6%)
Sep 2003
-
$26.06 M(+40.5%)
Jun 2003
-
$18.55 M(+6.6%)
Mar 2003
-
$17.40 M(-19.0%)
Dec 2002
$21.49 M(+40.5%)
$21.49 M(+0.8%)
Sep 2002
-
$21.33 M(+34.3%)
Jun 2002
-
$15.88 M(-9.6%)
Mar 2002
-
$17.56 M(+14.8%)
Dec 2001
$15.30 M(+37.7%)
$15.30 M(-6.0%)
Sep 2001
-
$16.28 M(+45.9%)
Jun 2001
-
$11.16 M(+28.8%)
Mar 2001
-
$8.67 M(-22.0%)
Dec 2000
$11.11 M(+52.2%)
$11.11 M(+24.6%)
Sep 2000
-
$8.92 M(+8.9%)
Jun 2000
-
$8.19 M(-26.7%)
Mar 2000
-
$11.17 M(+53.1%)
Dec 1999
$7.30 M(+2.8%)
$7.30 M(+35.2%)
Sep 1999
-
$5.40 M(-1.8%)
Jun 1999
-
$5.50 M(+14.6%)
Mar 1999
-
$4.80 M(-32.4%)
Dec 1998
$7.10 M(+9.2%)
$7.10 M(+16.4%)
Sep 1998
-
$6.10 M(+3.4%)
Jun 1998
-
$5.90 M(-19.2%)
Mar 1998
-
$7.30 M(+12.3%)
Dec 1997
$6.50 M(+32.7%)
$6.50 M(+30.0%)
Sep 1997
-
$5.00 M(-12.3%)
Jun 1997
-
$5.70 M(-5.0%)
Mar 1997
-
$6.00 M
Dec 1996
$4.90 M
-

FAQ

  • What is CTI BioPharma annual total current liabilities?
  • What is the all time high annual current liabilities for CTI BioPharma?
  • What is CTI BioPharma annual current liabilities year-on-year change?
  • What is CTI BioPharma quarterly total current liabilities?
  • What is the all time high quarterly current liabilities for CTI BioPharma?
  • What is CTI BioPharma quarterly current liabilities year-on-year change?

What is CTI BioPharma annual total current liabilities?

The current annual current liabilities of CTIC is $81.13 M

What is the all time high annual current liabilities for CTI BioPharma?

CTI BioPharma all-time high annual total current liabilities is $81.13 M

What is CTI BioPharma annual current liabilities year-on-year change?

Over the past year, CTIC annual total current liabilities has changed by +$14.48 M (+21.73%)

What is CTI BioPharma quarterly total current liabilities?

The current quarterly current liabilities of CTIC is $68.23 M

What is the all time high quarterly current liabilities for CTI BioPharma?

CTI BioPharma all-time high quarterly total current liabilities is $98.93 M

What is CTI BioPharma quarterly current liabilities year-on-year change?

Over the past year, CTIC quarterly total current liabilities has changed by -$30.71 M (-31.04%)